First-in-Human gene therapy injection aims to halt blindness
NCT ID NCT06460844
Summary
This is an early safety study testing a single injection of an experimental gene therapy called RTx-015 into the eye. It aims to see if the treatment is safe for adults with retinitis pigmentosa or choroideremia, two inherited diseases that cause vision loss. Researchers will give the injection to up to 18 people in small groups, starting with a low dose, and follow their health closely for five years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Retina Consultants of Texas Research Centers
Bellaire, Texas, 77401, United States
-
Retina Vitreous Associates Medical Group
Beverly Hills, California, 90211, United States
-
UCI Alpha Clinic
Orange, California, 92868, United States
-
UPMC Vision Institute
Pittsburgh, Pennsylvania, 15221, United States
Conditions
Explore the condition pages connected to this study.